First and foremost, vendors increasingly recognize that their value lies in pursuing solutions that address well-defined use cases, in contrast to earlier attempts to apply AI generically across the board to healthcare. Further, a growing body of published research describes consistent methods by which the clinical applications of AI are assessed and validated, mitigating concerns about the capabilities and safety of AI in healthcare . . .
See More on the Edge
Continue reading this article and more
with a GEN Edge subscription
The post AI Has the Potential to Improve Efficiency of Clinical Trials appeared first on GEN – Genetic Engineering and Biotechnology News.
